-
公开(公告)号:US20180273620A1
公开(公告)日:2018-09-27
申请号:US15743756
申请日:2016-07-15
申请人: UCB Biopharma SPRL
IPC分类号: C07K16/28
摘要: The present disclosure relates to antibody molecules comprising a binding domain specific to CD22, said binding domain comprising SEQ ID NO: 1, 2, 3, 4, 5 and 6 or 7. The disclosure also extends to pharmaceutical compositions comprising said antibody molecules and use of the antibody molecules/compositions in treatment.
-
42.
公开(公告)号:US10039826B2
公开(公告)日:2018-08-07
申请号:US15549528
申请日:2016-02-05
申请人: UCB Biopharma SPRL
IPC分类号: A61K39/395 , C07K16/28 , A61K47/18 , A61K47/26 , A61K47/12
摘要: The current invention relates to a new pharmaceutical formulation, in particular to a pharmaceutical formulation comprising a protein, more particularly an antibody as an active ingredient.
-
-
公开(公告)号:US09988446B2
公开(公告)日:2018-06-05
申请号:US14690892
申请日:2015-04-20
申请人: UCB Biopharma SPRL
IPC分类号: A61K39/395 , C07K16/24
CPC分类号: C07K16/244 , C07K2317/33 , C07K2317/92
摘要: The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
-
公开(公告)号:US09988383B2
公开(公告)日:2018-06-05
申请号:US15100697
申请日:2014-12-08
申请人: UCB BIOPHARMA SPRL
IPC分类号: C07D473/00 , C07D473/32 , A61K31/5377
CPC分类号: C07D473/00 , A61K31/5377 , C07D473/32
摘要: A series of substituted purine derivatives, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
-
-
公开(公告)号:US09956274B2
公开(公告)日:2018-05-01
申请号:US14991048
申请日:2016-01-08
申请人: UCB Biopharma SPRL
发明人: Terence Seward Baker
IPC分类号: C12N5/07 , A61K39/395 , A61K39/00 , A61K38/12 , C07K16/00 , C07K14/705 , C07K16/28
CPC分类号: A61K39/0005 , A61K2039/545 , A61K2039/6081 , A61K2039/62 , C07K14/705 , C07K16/28 , C07K2317/14 , C07K2317/20 , C07K2317/76
摘要: The present invention provides a method for generating a functionally modifying antibody to an ion channel comprising immunizing a host with a cyclic peptide comprising at least part of an extracellular sequence of said ion channel.
-
公开(公告)号:US09932342B2
公开(公告)日:2018-04-03
申请号:US15100690
申请日:2014-12-08
申请人: UCB BIOPHARMA SPRL
发明人: Mezher Hussein Ali , Daniel Christopher Brookings , Julien Alistair Brown , Victoria Elizabeth Jackson , Boris Kroeplien , John Robert Porter
IPC分类号: C07D487/04 , A61K31/519 , A61K31/5377
CPC分类号: C07D487/04 , A61K31/519 , A61K31/5377
摘要: A series of substituted imidazo[1,2-a]pyrimidine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
-
公开(公告)号:US09902768B2
公开(公告)日:2018-02-27
申请号:US14380310
申请日:2013-02-22
申请人: UCB Pharma S.A.
CPC分类号: C07K16/24 , C07K16/00 , C07K16/468 , C07K2317/31 , C07K2317/51 , C07K2317/522 , C07K2317/53 , C07K2317/55 , C07K2317/94
摘要: The present disclosure provides an asymmetric mixed antibody comprising two heavy chains or heavy chain fragments each comprising at least a variable region, a hinge region and a CH1 domain, wherein a first heavy chain or fragment thereof is a class IgG4 and has: a the inter-chain cysteine at position 127, numbered according to the Kabat numbering system, in the CH1 domain is substituted with another amino acid; and b optionally one or more of the amino acids positioned in the upper hinge region is substituted with cysteine, and wherein the second heavy chain or fragment thereof is characterized in that part or all of the chain has a different amino acid sequence to said first heavy chain in at least the region outside the variable region (for example the constant region), formulations comprising the same, therapeutic used of both of the above, and processes for preparing the antibodies and formulation.
-
公开(公告)号:US09902720B2
公开(公告)日:2018-02-27
申请号:US15038766
申请日:2014-12-08
申请人: UCB BIOPHARMA SPRL
IPC分类号: C07D471/04 , A61K31/437 , A61K31/506 , A61K31/5377
CPC分类号: C07D471/04 , A61K31/437 , A61K31/506 , A61K31/5377
摘要: A series of substituted pyrazolo[1,5-a]pyridine derivatives, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
-
-
-
-
-
-
-
-
-